Cohance Lifesciences Limited · NSE: COHANCE · BSE: 543064
Cohance Lifesciences
Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 05 Aug 2026.
Q1 FY27 · Consolidated
Revenue
422.26₹ Cr
−23.1% vs year ago
Net profit
(45.19)₹ Cr
Turned loss vs year ago
EPS, basic
(0.63)₹
Turned loss vs year ago
Net margin
-10.7%
−19.1 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 422.26 | −23.1% | (45.19) | Turned loss | (0.63) | 05 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 619.12 | +54.0% | 8.31 | −78.5% | 0.51 | 27 Jul 2026 |
| Q3 FY26Oct–Dec 2025 | 544.55 | +77.3% | 29.02 | −65.2% | 0.96 | 12 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 555.57 | +115.6% | 66.39 | −19.0% | 1.94 | 17 Jul 2026 |
| Q1 FY26Apr–Jun 2025 | 549.31 | +138.1% | 46.40 | −23.6% | 1.28 | 09 Sep 2025 |
| Q4 FY25Jan–Mar 2025 | 402.02 | +58.9% | 38.73 | −27.4% | 1.65 | 28 May 2025 |
| Q3 FY25Oct–Dec 2024 | 307.15 | +39.7% | 83.29 | +78.1% | 3.26 | 13 Feb 2025 |
| Q2 FY25Jul–Sep 2024 | 257.72 | +11.5% | 81.98 | +3.0% | 3.23 | 13 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 230.69 | −33.6% | 60.76 | −49.6% | 2.39 | 13 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 252.93 | −31.5% | 53.37 | −56.9% | 2.10 | 01 Jun 2024 |
| Q3 FY24Oct–Dec 2023 | 219.82 | −37.9% | 46.75 | −56.6% | 1.84 | 06 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 231.05 | −17.0% | 79.56 | +10.4% | 3.13 | 13 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 347.55 | +2.6% | 120.59 | +12.1% | 4.74 | 08 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 369.36 | +1.5% | 123.97 | +35.2% | 4.87 | 26 May 2023 |
| Q3 FY23Oct–Dec 2022 | 353.77 | −9.7% | 107.72 | −32.7% | 4.23 | 07 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 278.40 | −7.5% | 72.06 | −25.7% | 2.83 | 09 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 338.80 | +28.4% | 107.54 | +2.3% | 4.22 | 09 Aug 2022 |
| Q4 FY22Jan–Mar 2022 | 363.85 | +40.4% | 91.67 | +10.3% | 3.60 | 10 May 2022 |
| Q3 FY22Oct–Dec 2021 | 391.59 | +42.4% | 160.07 | +40.9% | 6.29 | 09 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 300.99 | +26.8% | 96.98 | +30.9% | 3.81 | 06 Nov 2021 |
| Q1 FY22Apr–Jun 2021 | 263.80 | +10.7% | 105.08 | +14.8% | 4.13 | 13 Aug 2021 |
| Q4 FY21Jan–Mar 2021 | 259.16 | +40.3% | 83.12 | +12.0% | 3.27 | 09 Jun 2021 |
| Q3 FY21Oct–Dec 2020 | 274.93 | — | 113.63 | — | 4.46 | 11 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 237.39 | — | 74.08 | — | 2.91 | 04 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 238.23 | — | 91.52 | — | 7.19 | 18 Aug 2020 |
| Q4 FY20Jan–Mar 2020 | 184.76 | — | 74.18 | — | 5.83 | 19 Jun 2020 |
Standalone results
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 359.89 | −25.6% | 1.41 | −97.3% | 0.04 | 05 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 567.55 | +71.9% | 34.56 | −22.1% | 0.90 | 27 Jul 2026 |
| Q3 FY26Oct–Dec 2025 | 481.58 | +74.9% | 47.29 | −45.2% | 1.24 | 12 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 497.79 | +110.9% | 94.29 | +23.5% | 2.46 | 17 Jul 2026 |
| Q1 FY26Apr–Jun 2025 | 483.58 | +117.7% | 52.57 | −19.2% | 1.38 | 09 Sep 2025 |
| Q4 FY25Jan–Mar 2025 | 330.17 | +35.6% | 44.34 | −17.0% | 1.74 | 28 May 2025 |
| Q3 FY25Oct–Dec 2024 | 275.39 | +29.4% | 86.35 | +64.9% | 3.39 | 13 Feb 2025 |
| Q2 FY25Jul–Sep 2024 | 236.06 | +5.1% | 76.33 | +2.1% | 3.00 | 13 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 222.09 | −35.4% | 65.08 | −47.6% | 2.56 | 13 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 243.52 | −33.2% | 53.43 | −58.9% | 2.10 | 01 Jun 2024 |
| Q3 FY24Oct–Dec 2023 | 212.83 | −38.9% | 52.36 | −52.2% | 2.06 | 06 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 224.62 | −19.3% | 74.73 | −5.3% | 2.94 | 13 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 344.03 | +1.5% | 124.29 | +9.0% | 4.88 | 08 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 364.39 | +0.1% | 130.16 | −42.0% | 5.11 | 26 May 2023 |
| Q3 FY23Oct–Dec 2022 | 348.49 | −11.0% | 109.47 | −20.1% | 4.30 | 07 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 278.40 | −7.5% | 78.92 | −31.5% | 3.10 | 09 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 338.80 | +28.4% | 114.05 | +40.0% | 4.48 | 09 Aug 2022 |
| Q4 FY22Jan–Mar 2022 | 363.85 | +40.4% | 224.46 | +248.3% | 8.82 | 10 May 2022 |
| Q3 FY22Oct–Dec 2021 | 391.59 | +42.4% | 137.00 | +40.3% | 5.38 | 09 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 300.99 | +26.8% | 115.20 | +76.3% | 4.53 | 06 Nov 2021 |
| Q1 FY22Apr–Jun 2021 | 263.80 | +10.7% | 81.44 | +0.3% | 3.20 | 13 Aug 2021 |
| Q4 FY21Jan–Mar 2021 | 259.16 | +40.3% | 64.45 | +21.1% | 2.53 | 09 Jun 2021 |
| Q3 FY21Oct–Dec 2020 | 274.93 | — | 97.63 | — | 3.84 | 11 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 237.39 | — | 65.33 | — | 2.57 | 04 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 238.23 | — | 81.23 | — | 6.38 | 18 Aug 2020 |
| Q4 FY20Jan–Mar 2020 | 184.76 | — | 53.24 | — | 4.18 | 19 Jun 2020 |
52 filings on record for this company.